Real world experience of patients treated with teclistamab: a BCMA-directed bispecific T-cell engaging therapy for multiple myeloma

被引:0
作者
Midha, Shonali [1 ]
Leblebjian, Houry [1 ]
Laubach, Jacob [1 ]
Mo, Clifton [1 ]
Sperling, Adam [1 ]
Nadeem, Omar [1 ]
Bianchi, Giada [2 ]
Hartley-Brown, Monique [1 ]
Ramsdell, Linda [1 ]
Donadio, Kristen [1 ]
Chun, Emerald [1 ]
Belanger, Megan [1 ]
Dobrusin, Irina [1 ]
Ghobrial, Irene [1 ]
Richardson, Paul [1 ]
Anderson, Kenneth [3 ]
Munshi, Nikhil [4 ]
机构
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Med Sch, LeBow Inst Myeloma Therapeut, Dana Farber Canc Inst, Jerome Lipper Ctr Multiple Myeloma Ctr, Boston, MA USA
[4] Harvard Med Sch, Vet Affairs Boston Healthcare Syst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-035
引用
收藏
页码:S53 / S53
页数:1
相关论文
empty
未找到相关数据